.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
US Department of Justice
Accenture
Moodys
Queensland Health
Covington
Deloitte
Merck
Dow

Generated: July 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 018828

« Back to Dashboard
NDA 018828 describes ZOVIRAX, which is a drug marketed by Glaxosmithkline, Valeant Bermuda, Mylan Pharms Inc, and VIB, and is included in six NDAs. It is available from seven suppliers. Additional details are available on the ZOVIRAX profile page.

The generic ingredient in ZOVIRAX is acyclovir. There are fifty-five drug master file entries for this compound. Sixty-three suppliers are listed for this compound. Additional details are available on the acyclovir profile page.

Summary for NDA: 018828

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Pharmacology for NDA: 018828

Ingredient-typeNucleoside Analog
Mechanism of ActionDNA Polymerase Inhibitors

Suppliers and Packaging for NDA: 018828

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZOVIRAX
acyclovir
CAPSULE;ORAL 018828 NDA Prestium Pharma, Inc. 40076-991 40076-991-55 100 CAPSULE in 1 BOTTLE (40076-991-55)
ZOVIRAX
acyclovir
CAPSULE;ORAL 018828 NDA REMEDYREPACK INC. 61786-186 61786-186-02 30 CAPSULE in 1 BLISTER PACK (61786-186-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Jan 25, 1985TE:ABRLD:Yes

Expired Orange Book Patents for NDA: 018828

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc
ZOVIRAX
acyclovir
CAPSULE;ORAL018828-001Jan 25, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Covington
Mallinckrodt
QuintilesIMS
Express Scripts
Moodys
Harvard Business School
Boehringer Ingelheim
Citi
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot